Bronchitol Resubmitted to Australian Pharmaceuticals Benefits Advisory Committee

12th Jul 11

Release Date: 12/07/2011 12:00am

Pharmaxis today announced that it has resubmitted an application for its cystic fibrosis product Bronchitol to the Pharmaceutical Benefits Advisory Committee for reimbursement on the Australian Pharmaceutical Benefits Scheme.


Read full media release - pdf

Categories: News and Media